手术及靶向治疗肺梭形细胞癌合并腺癌1例  

A case of pulmonary spindle cell carcinoma with adenocarcinoma treated by surgical and targeted therapy

作　　者：李俊 张万青 梁克 符详杰 LI Jun;ZHANG Wang-qing;LIANG Ke;FU Xiang-jie(Department of Cardiothoracic Surgery,Affiliated Hospital of Guangdong Medical University,Zhanjiang 524001,China)

机构地区：[1]广东医科大学附属医院心胸外科,广东湛江524001

出　　处：《广东医科大学学报》2024年第1期118-120,共3页Journal of Guangdong Medical University

摘　　要：1例74岁男性周围型肺癌患者行左上肺楔形切除+纵隔淋巴结摘除术,术后诊断为pT1bN1M0 IIB期肺梭形细胞癌合并腺癌,基因检测显示EGFR外显子19缺失突变,经过EGFR-TKI靶向药物治疗后病情控制稳定。A 74-year-old man with peripheral lung cancer underwent pulmonary wedge resection of left upper lobe and mediastinal lymph node resection.The patient was diagnosed as stage IIB(pT1bN1M0)pulmonary spindle cell carcinoma with adenocarcinoma.The genetic test revealed exon 19 deletion mutation of EGFR gene.The cancer was stable after EGFR-TKI targeted therapy.

关 键 词：肺梭形细胞癌 腺癌 靶向治疗 

分 类 号：R655.3[医药卫生—外科学]